News Release

ORIX Announces Capital Participation in Medical Equipment Sales Company INNOMEDICS
Supporting Further Enhancement of the Investees’ Corporate Value

Dec 12, 2014

TOKYO, Japan - December 12, 2014 - ORIX Corporation (TSE: 8591, NYSE: IX), a leading integrated financial services group announced today that it has agreed to acquire all common shares of a leading medical equipment sales company INNOMEDICS Medical Instruments, Inc. ("IMX")

IMX's shares will be jointly managed by ORIX and IMX's new management team, who will receive part of the common shares after the acquisition. Together, they aim to establish new management system while maintaining IMX's autonomy in running its existing business.

Since its founding in 1930, IMX has built a strong business foundation based on its core customers of leading medical institutions including university hospitals, as well as national and public hospitals. IMX now generates the highest revenues in the said industry in Tokyo and Chiba Prefectures (*1). Based on the fundamental philosophy of "solving medical problems through system," IMX provides an optimal mix of equipments, peripheral system and medical materials necessary for conducting high-level medical operations that require immediate attention such as surgeries and ICU.

In conjunction with this capital participation, ORIX will assist IMX with further fortification of its financial base and establishment of governance system by dispatching executives, in order to support IMX in becoming the leading company in the medical equipment sales industry where restructuring continues to take place. Furthermore, together with IMX's new management team, executives, and staffs, ORIX aims to increase IMX's corporate value by enhancing its service capability toward medical institutions through leveraging ORIX's financial services that target medical institutions, in addition to collaboration with ORIX's other business platforms.

Going forward, ORIX will continue to pursue equity investment opportunities in other medical equipment sales companies. ORIX aims to contribute to the further advancement of the medical equipment sales industry, one of the backbones of the medical industry in Japan, by assisting new investees in enhancing their corporate value while maintaining certain level of their managerial independence, and ultimately creating a dynamic group of medical equipment sales companies with strong business foundation that mutually support each other.

(*1) Source: R&D Co.,Ltd. "2014 Medical Equipments/Supplies Yearbook (Market Analysis)"

◆About INNOMEDICS
Company name INNOMEDICS Medical Instruments, Inc.
Headquarter location 4-17-15 Koishikawa, Bunkyo-ku, Tokyo
Representative Hirohisa Yamamoto
Established March 1951 (Founded April 1930)
Capital 78 million yen
Revenues 48,554 million yen (Fiscal year ended February 2014)
Number of employees 325 (as of February 2014)
Business Purchase, sales, proposal, rental,
and maintenance of medical equipment,
medical materials, and hospital facilities
URL http://www.innomedics.co.jp/eng/index.htmlOpen Link in New Window

Contact Information:
ORIX Corporation
Corporate Planning Department
Tel: +81-3-3435-3121

About ORIX:
ORIX Corporation (TSE: 8591; NYSE: IX) is a financial services group which provides innovative products and services to its customers by constantly pursuing new businesses. Established in 1964, from its start in the leasing business, ORIX has advanced into neighboring fields and at present has expanded into lending, investment, life insurance, banking, asset management, automobile related, real estate and environment and energy related businesses. Since entering Hong Kong in 1971, ORIX has spread its businesses globally by establishing locations in 35 countries and regions across the world. ORIX celebrates its 50th anniversary in 2014 and moving forward it aims to contribute to society while continuing to capture new business opportunities and sustain growth by promoting acceleration of its corporate strategy "Finance + Services." For more details, please visit our website: http://www.orix.co.jp/grp/en/

Caution Concerning Forward Looking Statements:
These documents may contain forward-looking statements about expected future events and financial results that involve risks and uncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause such a difference include, but are not limited to, those described under "Risk Factors" in the Company's annual report on Form 20-F filed with the United States Securities and Exchange Commission and under "4. Risk Factors" of the "Summary of Consolidated Financial Results" of the "Consolidated Financial Results April 1, 2013 - March 31, 2014."

View PDF of this release

2014 News Releases List